Headquarters : An der Goldgrube 12, 55131 Mainz, Germany
T: +49 6131 9084-0
F: +49 6131 9084-390
M: info@biontech.de
BioNTech SE is a German biotechnology company dedicated to the development and manufacture of active immunotherapies for a patient-specific approach to the treatment of serious diseases. It researches drugs based on messenger RNA (mRNA) for use as individualized cancer immunotherapies, as vaccines against infectious diseases and as protein replacement therapies for rare diseases, and also engineered cell therapy, novel antibodies and small molecule immunomodulators as treatment options for cancer.
Comments